Proven joint treatment for horses.
Arthramid 2.5% iPAAG is administered via intra-articular injection and integrates into the synovial membrane within approximately 14 days.
By supporting synovial health and restoring joint homeostasis, Arthramid helps improve joint fluid quality, reduce capsular stiffness, and support long-term joint comfort and function in horses.
Unlike temporary symptom-management approaches, Arthramid is designed to support the health and biomechanical function of the joint environment itself.
